Product NDC: | 0591-0796 |
Proprietary Name: | Sulfasalazine |
Non Proprietary Name: | Sulfasalazine |
Active Ingredient(s): | 500 mg/1 & nbsp; Sulfasalazine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-0796 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA085828 |
Marketing Category: | ANDA |
Start Marketing Date: | 19821001 |
Package NDC: | 0591-0796-10 |
Package Description: | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-0796-10) |
NDC Code | 0591-0796-10 |
Proprietary Name | Sulfasalazine |
Package Description | 1000 TABLET in 1 BOTTLE, PLASTIC (0591-0796-10) |
Product NDC | 0591-0796 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sulfasalazine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19821001 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | SULFASALAZINE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |